Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Telemedicine × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3 Gastrointestinal 1

Conditions

Colorectal Neoplasms 4 Polyps 1 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Pancreatic Adenocarcinoma 1 Malignant Hepatobiliary Neoplasm 1 Lung Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Gemcitabine 61 Fluorouracil 40 pembrolizumab 39 Oxaliplatin 39 Capecitabine 38 Bevacizumab 35 Leucovorin 33 Irinotecan 29 Cisplatin 25 Nivolumab 22 Paclitaxel 20 130-nm albumin-bound paclitaxel 19 Sorafenib 18 Cetuximab 17 Panitumumab 16 Albumin-Bound Paclitaxel 16 Cyclophosphamide 15 Radiotherapy 14 Docetaxel 13 Drug Therapy 12 Blood Specimen Collection 12 Exercise 10 budigalimab 9 atezolizumab 9 Taxes 9 IFL protocol 8 Folfox protocol 8 Carboplatin 8 trametinib 7 lenvatinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01274143 2016-04-08

Family CARE

University of Utah

Phase NA Completed

Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡